Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-01 Purchase |
2024-07-01 5:00 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
17,000 | $1.2159 | $20,670 | 304,458 (Indirect Direct) |
View |
| 2022-05-25 Purchase |
2022-05-27 4:10 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER |
2,482 | $2.58 | $6,404 | 232,558 (Indirect Direct) |
View |
| 2022-05-19 Purchase |
2022-05-23 4:41 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER |
13,256 | $2.7938 | $37,034 | 230,076 (Indirect Direct) |
View |
| 2021-08-16 Purchase(A) |
2022-04-21 4:50 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
4,922 | $7.866 | $38,716 | 216,820 (Direct) |
View |
| 2022-03-01 Purchase |
2022-03-07 7:13 pm |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
3,880 | $1.6372 | $6,352 | 72,707 (Indirect Direct) |
View |
| 2021-04-26 Purchase |
2021-04-27 4:03 pm |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
5,000 | $5 | $25,000 | 68,827 (Indirect Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 09:56 am |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
10,833 | $6 | $64,998 | 63,827 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:34 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
54,900 | $0 | 287,458 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:14 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
384,300 | $0 | 384,300 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-12 5:01 pm |
N/A 2032-09-09 |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
37,600 | $0 | 37,600 (Direct) |
View |
Ownership(A) |
2022-04-21 4:47 pm |
N/A 2030-12-15 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
0 | $0 | 26,424 (Direct) |
View |
| 2021-08-19 Option Award |
2021-09-17 4:16 pm |
N/A 2031-08-19 |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
38,135 | $0 | 38,135 (Direct) |
View |
| 2021-08-16 Exercise |
2021-08-17 9:03 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
4,922 | $7.866 | 216,820 (Direct) |
View |
Ownership |
2021-03-17 8:46 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer |
0 | $0 | 211,898 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:20 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
14,634 | $0 | 14,634 (Direct) |
View |